Centaur Pharmaceuticals

Centaur Pharmaceuticals launches for the first time in the world – a New Chemical Entity (NCE)–’WOXHeal®’ in the treatment of Diabetic Foot Ulcer

●        25% people with Diabetes develop a Diabetic Foot Ulcer  ●        1 in 5 people developing severe infection undergo foot amputation ●        Developed…

4 years ago

Centaur Pharmaceuticals & Kibow Biotech, USA, Announce a Strategic Alliance to Market Renadyl in India for Chronic Kidney Disease

Mumbai, March 08, 2018: Prevalence of Chronic Kidney Disease in India is 17.2% and rising[1] Dialysis is a painful and…

7 years ago